Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Abstracts Ahead of Print

PD1/PD-L1 axis in uro-oncology.


Kerstin Junker*, Markus Eckstein, Michelangelo Fiorentino and Rodolfo Montironi


DOI: 10.2174/1389450121666200326123700
View Abstract



Anti-VEGF Treatment in Corneal Diseases


Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia and Massimo Busin*


DOI: 10.2174/1389450121666200319111710
View Abstract


Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies


Devendra Kumar, Sahil Sharma, Sourav Kalra, Gurpreet Singh, Vikram Deep Monga and Bhupinder Kumar*


DOI: 10.2174/1389450121666200310115327
View Abstract




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63

Advertisement

Coronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog